SCHEMBL12656153

SCHEMBL12656153

CCNCCNc1ccccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.46
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
ICMT O60725 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
GAA P10253 3/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
NSD2 O96028 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233644 0.82 PSIP1 (0.50) PSIP1MAPTHTTL3MBTL1SMN1; SMN2
SCHEMBL479327 0.81 PSIP1 (0.53) PSIP1L3MBTL1SMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL3323107 0.79 PSIP1 (0.52) PSIP1L3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL27489390 0.78 SMN1; SMN2 (0.58) PSIP1MAPTHTTL3MBTL1SMN1; SMN2
SCHEMBL6232014 0.77 SMN1; SMN2 (0.53) PSIP1MAPTHTTL3MBTL1SMN1; SMN2
SCHEMBL29563275 0.77 SMN1; SMN2 (0.53) PSIP1MAPTHTTL3MBTL1SMN1; SMN2
SCHEMBL26416944 0.75 CA12 (0.57) PSIP1MAPTHTTL3MBTL1SMN1; SMN2
SCHEMBL8346697 0.75 MAPT (0.56) MAPTHTTL3MBTL1GAALMNA
SCHEMBL10798671 0.74 CHEK1 (0.54) PSIP1MAPTHTTL3MBTL1SMN1; SMN2
SCHEMBL4629056 0.74 RAB9A (0.51) PSIP1MAPTHTTL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2316829-A1 Heterocyclic derivatives as modulators of ion channels Vertex Pharmaceuticals Incorporated (US) 2011-05-04 EP disclosed
US-7456222-B2 Anti tubercular drug: compositions and methods SEQUELLA, INC. (US) 2008-11-25 US disclosed